Arun Rajasekaran: Demonstrating an Association Between Serum Anti-PLA2R Ab and Thrombosis Risk
Arun Rajasekaran, Nephrologist at Renal Medicine Associates, shared a post on X about a recent article he and his colleagues co-authored, published in Glamerular Diseases, adding:
“Our publication evaluating serum phospholipase A2 receptor antibody’s association with thromboembolic risk in membranous nephropathy is out.
This systematic review and meta-analysis is amongst the 1st to demonstrate an association between serum anti-PLA2R Ab and thrombosis risk”
Title: Serum Phospholipase A2 Receptor Antibody Is Associated with Thrombogenesis in Primary Membranous Nephropathy: A Systematic Review and Meta-Analysis
Authors: Paula Dibo, Henrique Alexsander Ferreira Neves, Raghunandan Konda, Alanis Yael Szyferman, Federico Napoli, Ifunanya Peculiar Nnajiofor, Clara Campoverde, Saeed Razaq, Arun Rajasekaran
Stay updated on all scientific advances with Hemostasis Today.
-
May 11, 2026, 14:42Julie Makani: WHO 2026 Guidelines on the Management of Childhood Illness for SCD
-
May 11, 2026, 14:41Rikke Johannessen: Acknowledging Africa CDC Leadership in Advancing Africa’s NCD Agenda
-
May 11, 2026, 14:41Ahmed Alanazi: Understanding the Causes of Hypercoagulation
-
May 11, 2026, 14:40Katerina Pavenski: What Should Be the Future Priorities in PBM
-
May 11, 2026, 14:18Maria Cherska: The Future of Familial Hypercholesterolemia Care
-
May 11, 2026, 13:59Dino Mehic: What Clinicians May Overlook in Bleeding Disorders
-
May 11, 2026, 13:48Ney Carter Borges: POAF and Long-Term Outcomes After Cardiac Surgery
-
May 11, 2026, 13:44Cosmo Godino։ Aortic Stenosis Is More Than a Valve Disease
-
May 11, 2026, 13:32Muhammad Aqib Faizan: Pulsed Field Ablation Improves Procedural Time Compared to the Conventional Ablation in AF